Lebenthal Global Advisors’s Labcorp LH Stock Holding History

Lebenthal Global Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-982	Closed	-$171K	–	356
2020 Q4	$171K	Buy	+982	New	+$170K	0.12%	111

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lebenthal Global Advisors's LH Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of Labcorp (LH) in Q1 2021, closing a stake of 982 shares — an estimated $171K sold.

Lebenthal Global Advisors first reported a position in LH in Q4 2020 and held it in 1 quarter. The position peaked at $171K in Q4 2020. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

Lebenthal Global Advisors reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 982 Labcorp shares in Q1 2021, an estimated $171K.
Lebenthal Global Advisors first reported a position in Labcorp in Q4 2020 and held it in 1 quarter.
Lebenthal Global Advisors's Labcorp position peaked at $171K in Q4 2020.
920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.